Multiple Sclerosis Clinical Trial
Official title:
Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop:Feasibility of Instrumented Gait Analysis in Clinical Practice.
People with Multiple Sclerosis (pwMS) often experience 'foot-drop' which means that the foot
is not adequately lifted during the so-called swing phase (foot is off the ground) during
walking which can lead to trips and falls. Functional Electrical Stimulation (FES) to the
shin muscles will aid lifting of the foot and therefore reduces the risk of trips and falls.
There have been several studies showing the benefits of FES to the walking of pwMS. The
proposed study aims to optimise the FES prescription and fitting care pathway for pwMS in
Edinburgh and the Lothians This will be achieved firstly through a survey to all clients
with MS in the last 5 years who have been regarded as suitable for FES. Secondly, a pilot
study will assess the suitability of the use of simple clinical measurement
(electrogoniometry) which will allow the measurement of the degree of foot-drop. The degree
is foot drop is usually assessed by the physiotherapist using visual observation. Using a
small device which can be quickly fitted to the patient's lower and foot for the duration of
a 2-6 minute walk, the physiotherapist will be able to quantify the degree of foot drop over
time. Such a measurement is especially important for people with MS who are often affected
by increased mental and physical fatigue.
Our first hypothesis is that the degree of foot-drop at the end of the walk is increased
compared to the start of the walk. Secondly, we hypothesise that the degree of foot drop is
less when the participant walks with the assistance of Functional Electrical Stimulation at
their next clinical appointment.
Participants People with MS (aged 18 or over) who are assessed for their suitability for FES
to treat foot-drop at Slateford Medical Centre are eligible for participation in this study.
For this feasibility study we aim to recruit at least 10 participants.
Recruitment Eligible patients will be given an information sheet by their physiotherapist
who will introduce the study at their initial appointment. A second appointment is made to
fit the FES unit and if the patient is willing to consider taking part in the study,
informed consent is taken.
Data collection To record the degree of foot-drop, one arm of the electrogoniometer will be
attached to the side of the participant's lower leg and the other arm to the shoe using
skin-friendly double sided adhesive tape.
The participant will then be asked to walk in their normal walking speed around the
corridors of the clinic for six minutes or shorter if the participant is not able to walk
for this duration. A data logger carried on the belt on the participant's waist will
continuously record the ankle angle data at 50Hz. Walking speed will be derived by measuring
the distance walked in the time recorded. Rate of perceived exertion on the Borg Scale will
be recorded every minute and immediately after the walk. Participants will also be asked to
fill in a questionnaire on their perceived walking performance (Multiple Sclerosis Walking
Scale 12).
At a follow-up appointment (1-2 weeks later) this data collection will be repeated with the
participant using the FES unit.
Data analysis. To assess the impact of fatigue on the ankle angle during prolonged walking,
ankle angle data in the first and last 60 seconds of the walk will be recorded. Two way
ANOVA will be employed to analyse both the effects of time (within session) and that of FES
use ('Off' and 'On', between sessions) on the degree of foot-drop if data are normally
distributed. Equivalent non-parametric statistics will be used for non normally distributed
data. Statistical significance will be accepted at p<0.05.
Inclusion criteria People with MS (aged 18-80) who are assessed for their suitability for
FES to treat foot-drop between September 2013 and March 2014 at Slateford Medical Centre are
eligible for participation in this study.
Exclusion criteria Patients with fixed ankle deformities, who are allergic to tape and who
are unable to walk for at least for two minutes (with or without walking aids) will be
excluded. Patients who experienced a relapse or any trauma affecting their walking between
the first fitting appointment and the follow-up appointment will also be excluded from the
study.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |